MCK - McKesson Corporation

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $999.33 DETAILS

Stock News

Here's Why McKesson (MCK) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Jul 15, 2026 06:40 AM • zacks.com

McKesson (MCK) Stock Dips While Market Gains: Key Facts

McKesson (MCK) closed at $803.37 in the latest trading session, marking a -1.1% move from the prior day.

Jul 14, 2026 03:01 PM • zacks.com

Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry

McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.

Jul 14, 2026 12:36 AM • zacks.com

5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds

Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positioned to generate wealth for investors amid improving industry prospect.

Jul 13, 2026 09:40 AM • zacks.com

Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a Bet

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Jul 09, 2026 06:31 AM • zacks.com

McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know

McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Jul 08, 2026 06:01 AM • zacks.com

McKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know

McKesson (MCK) closed the most recent trading day at $807.33, moving +2.95% from the previous trading session.

Jul 07, 2026 03:01 PM • zacks.com

Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?

McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Jul 06, 2026 09:11 AM • zacks.com

Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.

Jul 06, 2026 09:09 AM • fool.com

McKesson: The Healthcare Supplier On My Buy List This Summer, As Growth Accelerates

McKesson (MCK) is rated a buy, offering capital growth and dividend potential, underpinned by robust top-line and EPS growth. MCK's diversified portfolio, role in oncology and collaboration with big pharma names like AbbVie, and investment-grade Fitch rating support its investment case despite negative equity. Valuation appears compelling, with MCK trading at a forward earnings multiple of ~18x and estimated 18–22% upside by March 2028.

Jul 04, 2026 07:39 AM • seekingalpha.com

Here's Why You Should Retain McKesson Stock in Your Portfolio for Now

McKesson's growth in specialty pharma, oncology services and tech-driven solutions is boosting earnings, but policy and execution risks remain in focus.

Jul 02, 2026 11:16 AM • zacks.com

Here's Why McKesson (MCK) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Jul 02, 2026 06:46 AM • zacks.com

Here's Why McKesson (MCK) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Jun 30, 2026 06:52 AM • zacks.com

McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know

McKesson (MCK) concluded the recent trading session at $747.53, signifying a -2.09% move from its prior day's close.

Jun 29, 2026 02:51 PM • zacks.com

Why McKesson (MCK) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Jun 26, 2026 06:41 AM • zacks.com

McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It

McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Jun 24, 2026 06:00 AM • zacks.com

McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2027 financial results after market close on Wednesday, August 5, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services lea.

Jun 24, 2026 04:00 AM • businesswire.com

McKesson ideaShare 2026 Fuels Momentum for Independent Pharmacies

IRVING, Texas--(BUSINESS WIRE)--Last week, McKesson Corporation hosted McKesson ideaShare 2026, the company's annual event for independent community pharmacies, in Denver, Colorado.

Jun 23, 2026 04:00 AM • businesswire.com

McKesson (MCK) Stock Sinks As Market Gains: Here's Why

McKesson (MCK) closed the most recent trading day at $750.63, moving 3.74% from the previous trading session.

Jun 18, 2026 02:51 PM • zacks.com

McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Jun 10, 2026 06:01 AM • zacks.com